18615105

Source:http://linkedlifedata.com/resource/pubmed/id/18615105

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023473, umls-concept:C0032520, umls-concept:C0162735, umls-concept:C0205314, umls-concept:C0205344, umls-concept:C0392762, umls-concept:C0679622, umls-concept:C1439337, umls-concept:C1511790, umls-concept:C1519724, umls-concept:C1710360
pubmed:issue	2
pubmed:dateCreated	2009-2-11
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA106796, http://linkedlifedata.com/resource/pubmed/grant/CA18029, http://linkedlifedata.com/resource/pubmed/grant/K23 CA106796-04
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8704895
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1476-5551
pubmed:author	pubmed-author:AnanthnarayanSS, pubmed-author:CummingsCC, pubmed-author:DaridonAA, pubmed-author:DeiningerMM, pubmed-author:FacerGG, pubmed-author:McCormickFF, pubmed-author:OehlerV GVG, pubmed-author:QinJJ, pubmed-author:RadichJ PJP, pubmed-author:RamakrishnanRR, pubmed-author:ShahNN, pubmed-author:UngerMM, pubmed-author:WillisSS
pubmed:issnType	Electronic
pubmed:volume	23
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	396-9
pubmed:dateRevised	2011-5-3
pubmed:meshHeading	pubmed-meshheading:18615105-Fusion Proteins, bcr-abl, pubmed-meshheading:18615105-Humans, pubmed-meshheading:18615105-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:18615105-Microfluidic Analytical Techniques, pubmed-meshheading:18615105-Nanotechnology, pubmed-meshheading:18615105-Point Mutation, pubmed-meshheading:18615105-Polymerase Chain Reaction, pubmed-meshheading:18615105-Sensitivity and Specificity
pubmed:year	2009
pubmed:articleTitle	Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR.
pubmed:publicationType	Letter, Research Support, Non-U.S. Gov't, Evaluation Studies, Research Support, N.I.H., Extramural